Chameleon™ uniquely combines a high-pressure balloon catheter with Supervision™ technology – an integrated injection modality that provides targeted injection of diagnostic fluids (such as contrast media) or therapeutic fluids.
Chameleon™ is intended for use in PTA of the peripheral vasculature, including the femoral, iliac, and renal arteries and for the treatment of obstructive lesions of native or synthetic AV access sites. It allows physicians to visualize by injecting through the catheter, whether the balloon is inflated or deflated, all while maintaining wire position.
CHAMELEON™ ALLOWS PHYSICIANS TO MULTITASK THROUGH THE BALLOON
Perform a complete procedure through the ChameleonTM in both antegrade and retrograde cases, while maintaining wire position
Precise delivery of contrast directly to the treatment site may reduce the amount of contrast needed
Reduced need for
Complete the entire procedure through chameleon with the ability to perform angioplasty and injection of contrast media or therapeutic fluids
Perform reflux angiography while ChameleonTM occludes venous outflow, eliminating manual compression and enhancing operator safety
Fewer device exchanges and increased operator distance from radiation source may result in lower radiation exposure
ChameleonTM is simple and easy to use, taking standard high pressure balloon catheters to the next level
COVERING THE MAJORITY OF DIALYSIS ACCESS NEEDS
ChameleonTM is available in a sensible range of sizes covering most dialysis access procedures.
SupervisionTM is a proximal injection technology enabling simultaneous catheter based interventions and injection of diagnostic or therapeutic fluids in one device, eliminating multiple exchanges and promoting overall efficiency.
SupervisionTM technology is designed for a variety of catheter-based procedures and is now available on AV Medical’s flagship product for dialysis access maintenance – The ChameleonTM balloon catheter. SupervisionTM features result in ChameleonTM being the ONLY balloon catheter that provides simultaneous balloon inflation and injection of fluids while maintaining wire position.
The SupervisionTM injection modality comprises a port for injection fluids and a targeted exit port situated just proximal to the balloon. These unique features allow operators to potentially increase their distance from the radiation source, thus reducing radiation exposure. For Imaging procedures, precise delivery of contrast media can potentially reduce the amount of contrast media needed during the procedure.
ChameleonTM has been used successfully in several types of dialysis access procedures. The SupervisionTM feature has been shown to provide more efficient procedures with enhanced visibility.
CASE STUDY #01
76 year old, Female
AV Graft with venous anastomotic stenosis
Hands-free reflux angiography
CASE STUDY #02
80 year old, Male
AV fistula with anastomotic stenosis
Poor flow in a brachiocephalic fistula
Precise and efficient contrast delivery in retrograde approach.
No catheter exchanges needed to complete the case.
Tight stenosis near anastomosis
Balloon inflation at AV anastomosis
Post-inflation, deflate and advance balloon over the wire beyond anastomosis
Maintaining wire position, inject contrast through ChameleonTM to visualize area post treatment
AV Medical Technologies Ltd, a privately held medical device company headquartered in Israel, is dedicated to the development of advanced and efficient solutions in catheter-based interventions. The company is now focusing on its flagship catheter, the ChameleonTM, targeted for dialysis patients undergoing routine angioplasty procedures.
Over 3.7M patients worldwide suffer from irreversible kidney failure or end-stage renal disease (ESRD) and need dialysis or a kidney transplant to survive. Most patients on dialysis require angioplasty by balloon catheter to maintain adequate blood flow to their access site. AV Medical develops and commercializes the ChameleonTM PTA balloon catheter with SupervisionTM technology as an answer to this market’s growing needs. ChameleonTM provides more efficient angioplasty procedures that can potentially enhance both patient and operator safety.
ChameleonTM has been clinically tested in various types of dialysis access procedures.
Michael Tal, MD
Chief Business Officer
Chief Financial Officer
SCIENTIFIC ADVISORY BOARD
DHEERAJ RAJAN, MD
Associate Professor at University of Toronto, Canada
JOHN A. KAUFMAN, MD, MS
Professor of Radiology, Oregon Health Sciences, USA
GABRIEL BARTAL, MD
Director of Imaging and Interventional Radiology, Meir MC, Israel
ANTONIOS P. GASPARIS, MD, FACS
Director of the Center for Vein Care & Vascular Lab, Stony Brook, NY, US
effrey Hoggard, MD, Interventional Nephrologist with North Carolina Nephrology, P.A., will lead the session entitled, “Angioplasty and Imaging Combined: Introducing Chameleon™--The Next Generation of Dialysis Access Balloons.”